Haemonetics Corporation
Haemonetics Corporation（HAE）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · HAE · 截至 2025年9月30日
股东结构概览
316
机构持有人数
▲ 1 vs Q2
$2.50B
机构持仓总市值
▼ $1.55B vs Q2
45.45M
总流通股
freeFloat 98.76%
51.32M
13F 申报持股数
▼ 3.19M vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
HAE 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
BLACKROCK, INC. surgical & medical instruments & apparatus | 6.02M | 12.51% | 12.51% | $293.45B | Nov 12, 2025 | ▼ 344.1K |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 4.83M | 10.05% | 10.05% | $235.64B | Nov 7, 2025 | ▼ 118.7K |
NEUBERGER BERMAN GROUP LLC surgical & medical instruments & apparatus | 3.67M | 7.63% | 7.63% | $178.87B | Nov 12, 2025 | ▼ 607.2K |
AQR CAPITAL MANAGEMENT LLC surgical & medical instruments & apparatus | 2.13M | 4.42% | 4.42% | $102.81B | Nov 14, 2025 | ▲ 1.68M |
STATE STREET CORP surgical & medical instruments & apparatus | 1.80M | 3.74% | 3.74% | $87.77B | Nov 14, 2025 | ▼ 83.3K |
RIVER ROAD ASSET MANAGEMENT, LLC surgical & medical instruments & apparatus | 1.65M | 3.44% | 3.44% | $80.65B | Nov 12, 2025 | ▼ 886 |
UBS GROUP AG surgical & medical instruments & apparatus | 1.45M | 3.02% | 3.02% | $70.80B | Nov 13, 2025 | ▲ 582.8K |
ROYAL BANK OF CANADA surgical & medical instruments & apparatus | 1.26M | 2.62% | 2.62% | $61.45B | Nov 14, 2025 | ▲ 169.3K |
FMR LLC surgical & medical instruments & apparatus | 1.22M | 2.53% | 2.53% | $59.26B | Nov 13, 2025 | ▲ 380.0K |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 1.20M | 2.50% | 2.50% | $58.66B | Nov 12, 2025 | ▼ 41.2K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
24
增持
+5.83M 股3
新建仓
首次建仓23
减持
−5.68M 股0
清仓
完全退出净股数变化（前50家）
+147.6K
+5.83M / −5.68M
净新增持仓人
+4
新建 3 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
HAE 内幕交易记录
数据来源：SEC Form 4
近期内部人员净买入。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
1
买入笔数
1
卖出笔数
1.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Basil Michelle L EVP and General Counsel | May 15, 2026 | Award | 28,424 | — | — | 68.8K | Form 4 ↗ |
Basil Michelle L EVP and General Counsel | May 15, 2026 | Tax Withhold | 2,913 | $56.29 | $164.0K | 40.4K | Form 4 ↗ |
Chan Frank EVP, Chief Operating Officer | May 15, 2026 | Award | 27,535 | — | — | 32.9K | Form 4 ↗ |
Chan Frank EVP, Chief Operating Officer | May 15, 2026 | Tax Withhold | 546 | $56.29 | $30.7K | 5.4K | Form 4 ↗ |
DArecca James EVP, Chief Financial Officer | May 15, 2026 | Award | 29,312 | — | — | 54.4K | Form 4 ↗ |
DArecca James EVP, Chief Financial Officer | May 15, 2026 | Tax Withhold | 2,505 | $56.29 | $141.0K | 25.1K | Form 4 ↗ |
Maunsell Farris Maryanne VP, Chief Accounting Officer | May 15, 2026 | Award | 2,220 | — | — | 6.5K | Form 4 ↗ |
Maunsell Farris Maryanne VP, Chief Accounting Officer | May 15, 2026 | Tax Withhold | 197 | $56.29 | $11.1K | 4.3K | Form 4 ↗ |
Galvin Roy EVP, Chief Commercial Officer | May 15, 2026 | Award | 27,535 | — | — | 39.9K | Form 4 ↗ |
Galvin Roy EVP, Chief Commercial Officer | May 15, 2026 | Tax Withhold | 879 | $56.29 | $49.5K | 12.3K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Haemonetics Corporation（HAE）主要由机构投资者持有，机构持股比例约为 100.0%。公司内部人员持股约 1.24%，散户及公众持股约占剩余的 0.00%。
Haemonetics Corporation 最大机构股东为 BLACKROCK, INC.，截至 September 30, 2025 持有约 6.02 million 股，占总流通股的 12.51%。
目前共有 316 家机构持有 HAE 股票，合计持仓市值约 $2.50 billion，数据来源为最新 SEC 13F 申报。
常见问题
HAE ownershipHaemonetics Corporation（HAE）主要由机构投资者持有，机构持股约 100.0%。最大股东为 BLACKROCK, INC.，持股比例 12.51%。内部人员持股约 1.24%。数据来源 SEC Form 13F，截至 September 30, 2025。